Cervical dystonia and botulinum treatment: Is electromyographic guidance necessary?
β Scribed by J. D. Speelman; J. W. M. Brans
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 93 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
To the Editor:
Consensus exists that in the treatment of cervical dystonia, botulinum toxin (BTA) has to be applied within the selected muscles. Discussion continues whether this treatment must be administered under electromyographic (EMG) guidance.
To answer this question, one of us (J.D.S.), with 9 years experience with BTA treatment of cervical dystonia, inserted a 27-gauge hollow electrode needle, Teflon coated with a bar tip and connected to an electromyograph, into muscles selected for treatment with the EMG switched off. Before injecting BTA, the EMG was switched on to record the motor unit potentials (MUPs) and the interference pattern, using this method to inves-
π SIMILAR VOLUMES
To compare clinical parameters of patients treated with botulinum toxin type A (BTX) for treatment of idiopathic cervical dystonia (ICD) and for tardive cervical dystonia (TCD), we studied 156 patients (149 with ICD and 7 with TCD) who were treated with serial injections of BTX over 5 years. We hypo
## Abstract Seventyβsix consecutive patients with cervical dystonia (CD) treated with botulinum toxin were assessed with the Tsui rating scale, the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS), and a global scale of improvement. Tsui, TWSTRS, and TWSTRS subscale scores all showed sig
## Abstract We examined the impact of cervical dystonia (CD) and longβterm botulinum toxin (BTX) treatment on employment status. Data on employment status at onset of CD, at initiation of BTX treatment, and at evaluation of longβterm treatment were obtained from 62 CD patients aged 31β66 years (med
## Abstract Disorganization of sensory cortical somatotopy has been described in adult onset primary torsion dystonia (AOPTD). Although botulinum toxin type A (BTXβA) acts peripherally, some studies have suggested a central effect. Our primary hypothesis was that sensory cortical reorganization occ